16 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp.
21 Mar 24
Annual report
8:51pm
information regarding our clinical trial subjects or employees, could harm our reputation directly, compel us to comply with federal and/or state … , if approved;
decreased demand for our products;
injury to our reputation;
withdrawal of clinical trial participants and inability to continue
10-Q
2023 Q2
TSBX
Turnstone Biologics Corp.
1 Sep 23
Quarterly report
4:39pm
, including personal information regarding our clinical trial subjects or employees, could harm our reputation directly, compel us to comply with federal … to the market, if approved;
decreased demand for our products;
injury to our reputation;
withdrawal of clinical trial participants and inability
424B4
f19ya2 jyf5qx0p
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
fvthxpgmrq623qwtyg
23 Jun 23
IPO registration (amended)
9:49pm
S-1
EX-10.10
vef mxey70cpsqvr
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.9
h609 54k7dkz5u4
12 Jun 23
IPO registration
4:28pm
S-1
EX-2.1
v12 es7u24xj3
12 Jun 23
IPO registration
4:28pm
S-1
wha6mwz
12 Jun 23
IPO registration
4:28pm
DRS
EX-10.9
crkbm
15 May 23
Draft registration statement
12:00am
DRS
EX-2.1
54vfgd5g6xnxfp9yj3w
15 May 23
Draft registration statement
12:00am
DRS
EX-10.10
l4so6
15 May 23
Draft registration statement
12:00am
DRS
aneobj lq
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next